SG10201802647QA - Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives - Google Patents
Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivativesInfo
- Publication number
- SG10201802647QA SG10201802647QA SG10201802647QA SG10201802647QA SG10201802647QA SG 10201802647Q A SG10201802647Q A SG 10201802647QA SG 10201802647Q A SG10201802647Q A SG 10201802647QA SG 10201802647Q A SG10201802647Q A SG 10201802647QA SG 10201802647Q A SG10201802647Q A SG 10201802647QA
- Authority
- SG
- Singapore
- Prior art keywords
- glutarimide derivatives
- methods
- pharmaceutical composition
- composition based
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013116826A RU2562773C3 (en) | 2013-04-12 | GLUTARIMIDE DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION BASED ON THEM, METHODS OF THEIR PRODUCTION |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201802647QA true SG10201802647QA (en) | 2018-05-30 |
Family
ID=51689819
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201802650WA SG10201802650WA (en) | 2013-04-12 | 2014-04-10 | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
SG10201802648SA SG10201802648SA (en) | 2013-04-12 | 2014-04-10 | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
SG10201802647QA SG10201802647QA (en) | 2013-04-12 | 2014-04-10 | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
SG11201508394UA SG11201508394UA (en) | 2013-04-12 | 2014-04-10 | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201802650WA SG10201802650WA (en) | 2013-04-12 | 2014-04-10 | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
SG10201802648SA SG10201802648SA (en) | 2013-04-12 | 2014-04-10 | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201508394UA SG11201508394UA (en) | 2013-04-12 | 2014-04-10 | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
Country Status (15)
Country | Link |
---|---|
US (8) | US9815814B2 (en) |
EP (3) | EP2985282A4 (en) |
JP (4) | JP6529958B2 (en) |
KR (3) | KR102254315B1 (en) |
CN (4) | CN106061962B (en) |
AU (5) | AU2014251442A1 (en) |
BR (3) | BR122020010210B1 (en) |
CA (1) | CA2909057C (en) |
EA (4) | EA032951B1 (en) |
IL (4) | IL266301B2 (en) |
MX (4) | MX2020005736A (en) |
SG (4) | SG10201802650WA (en) |
UA (1) | UA121299C2 (en) |
WO (1) | WO2014168522A1 (en) |
ZA (3) | ZA201508278B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA121299C2 (en) * | 2013-04-12 | 2020-05-12 | Общєство С Огранічєнной Отвєтствєнностью "Фармінтерпрайсез" | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
RU2552929C1 (en) * | 2013-11-14 | 2015-06-10 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Pharmaceutical composition, containing derivatives of glutarimides, and their application for treatment of eosinophilic diseases |
RU2628800C2 (en) * | 2014-03-12 | 2017-08-22 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Amide compounds, methods for production, application as means for treatment and prevention of diseases caused by rna-containing viruses |
CN106539792B (en) * | 2016-11-07 | 2017-08-25 | 王晓旭 | A kind of medicine for treating hyperlipemia |
MD4788C1 (en) * | 2017-09-07 | 2022-09-30 | Ооо "Валента-Интеллект" | Use of a glutarimide derivative to treat diseases related to the aberrant activity of cytokines |
JP2022506892A (en) * | 2018-11-01 | 2022-01-17 | アハンムネ バイオサイエンシーズ プライベート リミテッド | New imidazole compound, its synthesis method and its use |
RU2712281C1 (en) * | 2018-11-23 | 2020-01-28 | Общество С Ограниченной Ответственностью "Хемиммьюн Терапьютикс" | Use of a derivative glutarimide to overcome resistance to steroids and therapy of diseases associated with aberrant signaling of interferon gamma |
CN115803026A (en) * | 2020-06-26 | 2023-03-14 | 瓦伦塔有限责任公司 | Use of glutarimide derivatives for the treatment of diseases associated with abnormal interleukin-6 activity |
WO2023121519A1 (en) * | 2021-12-23 | 2023-06-29 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Use of 1-[2-(1-methylimidazole-4-yl)-ethyl]perhydroazine-2,6-dione for treating covid-19 |
WO2023177329A1 (en) * | 2022-03-18 | 2023-09-21 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Use of 1-(2-(1н-imidazole-4-yl)ethyl)piperidine-2,6-dione to treat cough caused by viral infections |
WO2023191666A1 (en) * | 2022-03-29 | 2023-10-05 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Crystalline form of 1-(2-(1н-imidazole-4-yl)ethyl)piperidine-2,6-dione and use thereof |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3081308A (en) * | 1959-12-29 | 1963-03-12 | Searle & Co | 5-carbocyclic-3-imidomethyloxazolidines and process |
US3171839A (en) * | 1961-05-18 | 1965-03-02 | Searle & Co | 4-alkyl-1-(cyclic imidoalkyl) piperidines |
GB1033251A (en) * | 1961-09-07 | 1966-06-22 | Distillers Co Yeast Ltd | Glutarimide derivatives |
US3963691A (en) * | 1974-10-07 | 1976-06-15 | Merck & Co., Inc. | Synthetic antigens of luteinizing hormone releasing hormone |
US4261990A (en) * | 1979-03-09 | 1981-04-14 | Ciba-Geigy Corporation | N-alkyleneiminoalkyl-dicarboximides as antiallergics and antiasthmatics |
JPS606686A (en) | 1983-06-27 | 1985-01-14 | Kissei Pharmaceut Co Ltd | Thiophene derivative and its preparation |
JPS6066686A (en) | 1983-09-19 | 1985-04-16 | Toshiba Corp | Speed controller of line drive motor |
SE8600261D0 (en) * | 1986-01-21 | 1986-01-21 | Lundblad Leif | INDOLOKINOXALINES WITH SUBSTITUTIONS IN 6-POSITION CONTAINING CYCLIC GROUPS |
SU1836365A3 (en) * | 1991-01-24 | 1993-08-23 | Физиko-Xиmичeckий Иhctиtуt Иm.A.B.Бoгatckoгo;Hии@ Фapmakoлoгии Poccийckoй Amh | Method for obtaining n-(1-piperazinyl)butylglutarimidines |
FR2737725B1 (en) | 1995-08-08 | 1997-10-31 | Valentonine | NOVEL ACYLATED DERIVATIVES OF MELATONIN AND MELATONINERGIC ANALOGS, THEIR PREPARATION PROCESS AND THEIR USE AS MEDICAMENTS |
RU2141483C1 (en) | 1997-07-04 | 1999-11-20 | Небольсин Владимир Евгеньевич | Peptide derivatives or their pharmaceutically acceptable salts, method of their synthesis, use and pharmaceutical composition |
WO1999012910A1 (en) * | 1997-09-11 | 1999-03-18 | Nissan Chemical Industries, Ltd. | Pyrazole compounds and plant disease control agent |
ITMI991578A1 (en) * | 1999-07-15 | 2001-01-15 | Recordati Ind Chimica E Farma | STARCHES AND CYCLIC IMIDES EQUIPPED WITH SELECTIVE ANTAGONIST ACTIVITY FOR THE ADRENERGIC RECEPTOR |
US6413428B1 (en) | 1999-09-16 | 2002-07-02 | Berger Instruments, Inc. | Apparatus and method for preparative supercritical fluid chromatography |
DE10002509A1 (en) * | 2000-01-21 | 2001-07-26 | Gruenenthal Gmbh | New substituted glutarimide derivatives are IL-12 antagonists, are useful as immunomodulators and for the treatment of angiopathy, hematological or oncological disorders |
US7030150B2 (en) * | 2001-05-11 | 2006-04-18 | Trimeris, Inc. | Benzimidazole compounds and antiviral uses thereof |
AU2003263393A1 (en) * | 2002-09-04 | 2004-03-29 | Glenmark Pharmaceuticals Limited | New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
RU2337908C2 (en) | 2003-06-12 | 2008-11-10 | Ново Нордиск А/С | Pyridinyl carbamates as hormone-sensitive lipase inhibitors |
CN1260218C (en) * | 2003-11-06 | 2006-06-21 | 天津药物研究院 | PDF enzyme inhibitor-hydroxamic acid serial compounds synthetic method and use thereof |
WO2006040646A1 (en) * | 2004-10-14 | 2006-04-20 | Pfizer, Inc. | Benzimidazole or indole amides as inhibitors of pin1 |
BRPI0607062A2 (en) * | 2005-02-28 | 2009-08-04 | Japan Tobacco Inc | aminopyridine compound with syk inhibitory activity, pharmaceutical composition and therapeutic agent comprising the same |
EP1741709A1 (en) * | 2005-06-28 | 2007-01-10 | Sanofi-Aventis Deutschland GmbH | Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
WO2007007054A1 (en) | 2005-07-08 | 2007-01-18 | Cancer Research Technology Limited | Phthalamides, succinimides and related compounds and their use as pharmaceuticals |
US20120157387A1 (en) * | 2006-11-28 | 2012-06-21 | Apotex Technologies Inc. | Orally bioavailable d-gamma-glutamyl-d-tryptophan |
US9453005B2 (en) * | 2008-09-16 | 2016-09-27 | The Trustees Of The University Of Pennsylvania | Inhibition of influenza M2 proton channel |
EA025224B1 (en) * | 2010-04-15 | 2016-12-30 | Байота Сайентифик Менеджмент Пти Лтд. | USE OF 3-ETHOXY-6-{2-[1-(6-METHYL-PYRIDAZIN-3-YL)PIPERIDIN-4-YL]ETHOXY}BENZO[d]ISOXAZOLE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN THE TREATMENT OR ALLEVIATION OF SYMPTOMS OF ASTHMA |
TW201217312A (en) * | 2010-09-22 | 2012-05-01 | Gruenenthal Gmbh | Substituted benzamide compounds |
US20120157382A1 (en) * | 2010-12-21 | 2012-06-21 | Siegfried Krimmer | Pharmaceutical glp-1 compositions having an improved release profile |
RU2665688C2 (en) * | 2013-04-12 | 2018-09-04 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Dicarboxylic acid bisamide derivatives, their application, the pharmaceutical composition on their basis, methods for their production |
UA121299C2 (en) * | 2013-04-12 | 2020-05-12 | Общєство С Огранічєнной Отвєтствєнностью "Фармінтерпрайсез" | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
RU2552929C1 (en) * | 2013-11-14 | 2015-06-10 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Pharmaceutical composition, containing derivatives of glutarimides, and their application for treatment of eosinophilic diseases |
-
2014
- 2014-04-10 UA UAA201511008A patent/UA121299C2/en unknown
- 2014-04-10 SG SG10201802650WA patent/SG10201802650WA/en unknown
- 2014-04-10 JP JP2016507512A patent/JP6529958B2/en active Active
- 2014-04-10 EP EP14782170.6A patent/EP2985282A4/en not_active Withdrawn
- 2014-04-10 KR KR1020207016268A patent/KR102254315B1/en active IP Right Grant
- 2014-04-10 SG SG10201802648SA patent/SG10201802648SA/en unknown
- 2014-04-10 KR KR1020157032457A patent/KR102255929B1/en active IP Right Grant
- 2014-04-10 EP EP20178488.1A patent/EP3725785B1/en active Active
- 2014-04-10 MX MX2020005736A patent/MX2020005736A/en unknown
- 2014-04-10 CN CN201480032755.8A patent/CN106061962B/en not_active Expired - Fee Related
- 2014-04-10 MX MX2020005735A patent/MX2020005735A/en unknown
- 2014-04-10 BR BR122020010210-1A patent/BR122020010210B1/en not_active IP Right Cessation
- 2014-04-10 US US14/783,911 patent/US9815814B2/en active Active
- 2014-04-10 SG SG10201802647QA patent/SG10201802647QA/en unknown
- 2014-04-10 MX MX2015014336A patent/MX2015014336A/en unknown
- 2014-04-10 EP EP20178489.9A patent/EP3722290B1/en active Active
- 2014-04-10 EA EA201792072A patent/EA032951B1/en unknown
- 2014-04-10 BR BR122020010204-7A patent/BR122020010204B1/en active IP Right Grant
- 2014-04-10 MX MX2020005738A patent/MX2020005738A/en unknown
- 2014-04-10 BR BR112015025804-2A patent/BR112015025804B1/en not_active IP Right Cessation
- 2014-04-10 CN CN201910437243.4A patent/CN110172055B/en active Active
- 2014-04-10 IL IL266301A patent/IL266301B2/en unknown
- 2014-04-10 SG SG11201508394UA patent/SG11201508394UA/en unknown
- 2014-04-10 EA EA201591957A patent/EA031392B1/en unknown
- 2014-04-10 EA EA201792071A patent/EA033054B1/en unknown
- 2014-04-10 EA EA201792597A patent/EA032938B1/en not_active IP Right Cessation
- 2014-04-10 CN CN201910437241.5A patent/CN110229140B/en active Active
- 2014-04-10 AU AU2014251442A patent/AU2014251442A1/en not_active Abandoned
- 2014-04-10 CA CA2909057A patent/CA2909057C/en active Active
- 2014-04-10 CN CN201910437242.XA patent/CN110128406B/en active Active
- 2014-04-10 WO PCT/RU2014/000264 patent/WO2014168522A1/en active Application Filing
- 2014-04-10 KR KR1020207016274A patent/KR102296182B1/en active IP Right Grant
-
2015
- 2015-10-11 IL IL241998A patent/IL241998B/en active IP Right Grant
- 2015-11-10 ZA ZA2015/08278A patent/ZA201508278B/en unknown
-
2016
- 2016-05-10 ZA ZA2016/03109A patent/ZA201603109B/en unknown
- 2016-05-10 ZA ZA2016/03108A patent/ZA201603108B/en unknown
-
2017
- 2017-09-28 US US15/718,226 patent/US10155744B2/en active Active
- 2017-09-28 US US15/718,207 patent/US10155743B2/en active Active
- 2017-09-28 US US15/718,316 patent/US10155747B2/en active Active
- 2017-09-28 US US15/718,274 patent/US10196377B2/en active Active
- 2017-09-28 US US15/718,252 patent/US10155745B2/en active Active
- 2017-09-28 US US15/718,295 patent/US10155746B2/en active Active
-
2018
- 2018-09-27 AU AU2018236805A patent/AU2018236805C1/en not_active Ceased
- 2018-11-07 JP JP2018209575A patent/JP6843103B2/en active Active
- 2018-11-07 JP JP2018209574A patent/JP6620324B2/en active Active
- 2018-11-07 JP JP2018209573A patent/JP6627039B2/en active Active
- 2018-11-15 US US16/192,065 patent/US10377739B2/en active Active
-
2019
- 2019-04-29 IL IL266300A patent/IL266300B/en unknown
- 2019-04-29 IL IL266302A patent/IL266302B/en unknown
-
2020
- 2020-06-02 AU AU2020203632A patent/AU2020203632B2/en active Active
- 2020-06-02 AU AU2020203630A patent/AU2020203630B2/en active Active
- 2020-06-15 AU AU2020203968A patent/AU2020203968B2/en not_active Ceased
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL266301A (en) | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives | |
HK1215378A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
HK1215567A1 (en) | Five-and-six-membered heterocyclic compound, and preparation method, pharmaceutical composition and use thereof | |
HK1212980A1 (en) | Pyridinone derivatives, preparation process and pharmaceutical use thereof | |
HK1221223A1 (en) | Dicarboxylic acid bisamide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing dicarboxylic acid bisamide derivatives | |
HK1223360A1 (en) | Novel indolizine derivatives, method for the production thereof and pharmaceutical compositions containing same | |
EP3012256A4 (en) | Benzimidazole-2-piperazine heterocyclic compound, pharmaceutical composition thereof, preparation method and use thereof | |
EP3037099A4 (en) | Pharmaceutical composition, preparation method therefor and use thereof | |
EP3078659A4 (en) | 3-furyl-2-cyano-2-acrylamide derivative, preparation method therefor, pharmaceutical composition and use thereof | |
IL238851A0 (en) | Pyrrolidine derivatives, pharmaceutical compositions and uses thereof | |
HK1212968A1 (en) | Aminocyclobutane derivatives, method for preparing same and the use thereof as drugs | |
HUP1300393A2 (en) | Quinazoline derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same |